Positive News SentimentPositive NewsNASDAQ:NARI Inari Medical (NARI) Stock Forecast, Price & News $66.31 -0.37 (-0.55%) (As of 12:21 PM ET) Add Compare Share Share Today's Range$65.95▼$67.2550-Day Range$55.60▼$71.6752-Week Range$52.59▼$83.84Volume78,348 shsAverage Volume780,607 shsMarket Capitalization$3.80 billionP/E RatioN/ADividend YieldN/APrice Target$85.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Inari Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside27.8% Upside$85.25 Price TargetShort InterestHealthy8.59% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.89Based on 2 Articles This WeekInsider TradingSelling Shares$8.43 M Sold Last QuarterProj. Earnings Growth725.00%From $0.04 to $0.33 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.62 out of 5 starsMedical Sector394th out of 970 stocksSurgical & Medical Instruments Industry51st out of 101 stocks 3.4 Analyst's Opinion Consensus RatingInari Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $85.25, Inari Medical has a forecasted upside of 27.8% from its current price of $66.68.Amount of Analyst CoverageInari Medical has only been the subject of 3 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted8.59% of the float of Inari Medical has been sold short.Short Interest Ratio / Days to CoverInari Medical has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Inari Medical has recently decreased by 6.68%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInari Medical does not currently pay a dividend.Dividend GrowthInari Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NARI. Previous Next 3.3 News and Social Media Coverage News SentimentInari Medical has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Inari Medical this week, compared to 3 articles on an average week.Search Interest8 people have searched for NARI on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Inari Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inari Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,432,648.00 in company stock.Percentage Held by Insiders11.90% of the stock of Inari Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.75% of the stock of Inari Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Inari Medical are expected to grow by 725.00% in the coming year, from $0.04 to $0.33 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inari Medical is -222.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inari Medical is -222.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInari Medical has a P/B Ratio of 8.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Inari Medical (NASDAQ:NARI) StockInari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Read More NARI Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NARI Stock News HeadlinesSeptember 21, 2023 | americanbankingnews.comWilliam Hoffman Sells 25,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) StockSeptember 14, 2023 | finance.yahoo.comCFO Mitch Hill Sells 6,500 Shares of Inari Medical IncSeptember 29, 2023 | The Oxford Club (Ad)Better Than Oil Stocks?The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. August 11, 2023 | finance.yahoo.comWall Street Analysts See a 36.39% Upside in Inari Medical, Inc. (NARI): Can the Stock Really Move This High?August 7, 2023 | markets.businessinsider.comInari Medical (NARI) Receives a Hold from Truist FinancialAugust 6, 2023 | finance.yahoo.comIs Inari Medical, Inc. (NASDAQ:NARI) Expensive For A Reason? A Look At Its Intrinsic ValueAugust 4, 2023 | msn.comMorgan Stanley Reiterates Inari Medical (NARI) Overweight RecommendationAugust 4, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), Inari Medical (NARI) and Sarepta Therapeutics (SRPT)September 29, 2023 | UNKNOWN (Ad)The Next Best AI Stock to Watch After NvidiaThis emerging NASDAQ company may be the best AI stock to watch in the AI boom. August 3, 2023 | msn.comInari Medical Stock Gained 21% on Thursday - Here's Why It SoaredAugust 3, 2023 | finance.yahoo.comWhy Shares of Inari Medical Are Up ThursdayAugust 3, 2023 | msn.comInari Medical GAAP EPS of $0.04 beats by $0.16, revenue of $119M beats by $2.28MAugust 3, 2023 | finance.yahoo.comInari Medical Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comInari Medical, Inc. (NARI) Tops Q2 Earnings and Revenue EstimatesAugust 1, 2023 | markets.businessinsider.comInari Medical earnings: here's what Wall Street expectsJuly 31, 2023 | msn.comInari Medical: Approaching Interesting LevelsJuly 26, 2023 | finance.yahoo.comInari Medical to Present at the 43rd Annual Canaccord Growth ConferenceJuly 20, 2023 | finance.yahoo.comShould You Think About Buying Inari Medical, Inc. (NASDAQ:NARI) Now?July 13, 2023 | finance.yahoo.comInari Medical to Announce Second Quarter 2023 Financial ResultsJuly 6, 2023 | finance.yahoo.comQooQoo Healthcare Marketing Agency Earns Multiple Marketing AwardsJuly 4, 2023 | msn.comReasons to Add Inari Medical (NARI) Stock to Your PortfolioJune 22, 2023 | benzinga.comCatheter Introducer Sheaths Market Size to Surpass US$ 2.06 Billion by 2031 - Growth Plus ReportsJune 15, 2023 | seekingalpha.comNARI Inari Medical, Inc.June 12, 2023 | finance.yahoo.comInari Medical (NASDAQ:NARI) shareholders have earned a 7.4% CAGR over the last three yearsJune 7, 2023 | finance.yahoo.comInari Medical Announces Commercial Launch of RevCore™ and Triever16 Curve™, Two New Purpose-Built Products for Addressing Venous Stent Thrombosis and Venous ThromboembolismMay 25, 2023 | finance.yahoo.comInari Medical Announces the Release of 2022 Ethos and Sustainability ReportMay 24, 2023 | finance.yahoo.comArtelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint InstabilitySee More Headlines Receive NARI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address NARI Company Calendar Last Earnings8/02/2023Today9/29/2023Next Earnings (Estimated)11/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NARI CUSIPN/A CIK1531048 Webwww.inarimedical.com Phone877-923-4747FaxN/AEmployees1,100Year FoundedN/APrice Target and Rating Average Stock Price Forecast$85.25 High Stock Price Forecast$100.00 Low Stock Price Forecast$65.00 Forecasted Upside/Downside+27.8%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.30) Trailing P/E RatioN/A Forward P/E Ratio1,667.00 P/E GrowthN/ANet Income$-29,270,000.00 Net Margins-3.66% Pretax Margin-2.80% Return on Equity-3.80% Return on Assets-3.18% Debt Debt-to-Equity RatioN/A Current Ratio7.63 Quick Ratio6.97 Sales & Book Value Annual Sales$383.47 million Price / Sales9.97 Cash FlowN/A Price / Cash FlowN/A Book Value$7.77 per share Price / Book8.58Miscellaneous Outstanding Shares57,350,000Free Float50,527,000Market Cap$3.82 billion OptionableNot Optionable Beta1.00 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Andrew J. Hykes (Age 49)CEO, Pres & Director Comp: $863.78kMr. Mitchell C. Hill (Age 64)Chief Financial Officer Comp: $811.08kDr. Thomas M. Tu M.D. (Age 50)Chief Medical Officer Comp: $812.94kMr. Paul A. Koehn (Age 60)Sr. VP of Operations Mr. John Hsu C.F.A.VP of Investor RelationsMs. Angela AhmadGen. Counsel & Sec.Mr. Eric KhairySr. VP of MarketingMr. John R. Borrell (Age 56)Sr. VP of Sales Ms. Tara DunnSr. VP of Clinical Affairs & Market Devel.Mr. Brian StraussSr. VP of EngineeringMore ExecutivesKey CompetitorsGlaukosNYSE:GKOSMerit Medical SystemsNASDAQ:MMSIIntegra LifeSciencesNASDAQ:IARTHaemoneticsNYSE:HAEAxonicsNASDAQ:AXNXView All CompetitorsInsiders & InstitutionsWilliam HoffmanSold 25,000 sharesTotal: $1.67 M ($66.74/share)Mitch C HillSold 6,500 sharesTotal: $441,025.00 ($67.85/share)Wolverine Trading LLCSold 3,900 shares on 8/23/2023Ownership: 0.000%Comerica BankBought 9,434 shares on 8/22/2023Ownership: 0.016%Virginia Retirement Systems ET ALBought 6,200 shares on 8/22/2023Ownership: 0.011%View All Insider TransactionsView All Institutional Transactions NARI Stock - Frequently Asked Questions Should I buy or sell Inari Medical stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last year. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NARI shares. View NARI analyst ratings or view top-rated stocks. What is Inari Medical's stock price forecast for 2023? 6 brokerages have issued 1-year price objectives for Inari Medical's shares. Their NARI share price forecasts range from $65.00 to $100.00. On average, they anticipate the company's share price to reach $85.25 in the next twelve months. This suggests a possible upside of 27.8% from the stock's current price. View analysts price targets for NARI or view top-rated stocks among Wall Street analysts. How have NARI shares performed in 2023? Inari Medical's stock was trading at $63.56 at the beginning of the year. Since then, NARI stock has increased by 4.9% and is now trading at $66.68. View the best growth stocks for 2023 here. When is Inari Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023. View our NARI earnings forecast. How were Inari Medical's earnings last quarter? Inari Medical, Inc. (NASDAQ:NARI) issued its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.04 EPS for the quarter, beating the consensus estimate of ($0.14) by $0.18. The business earned $119.01 million during the quarter, compared to the consensus estimate of $116.67 million. Inari Medical had a negative net margin of 3.66% and a negative trailing twelve-month return on equity of 3.80%. Inari Medical's revenue for the quarter was up 28.3% on a year-over-year basis. During the same period in the previous year, the business posted ($0.19) earnings per share. What ETFs hold Inari Medical's stock? ETFs with the largest weight of Inari Medical (NASDAQ:NARI) stock in their portfolio include MFAM Small-Cap Growth ETF (MFMS), Motley Fool Small-Cap Growth ETF (TMFS), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Principal Healthcare Innovators ETF (BTEC) and IQ Healthy Hearts ETF (HART).iShares U.S. Medical Devices ETF (IHI). What guidance has Inari Medical issued on next quarter's earnings? Inari Medical issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $482.00 million-$492.00 million, compared to the consensus revenue estimate of $483.82 million. What other stocks do shareholders of Inari Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY). When did Inari Medical IPO? (NARI) raised $110 million in an initial public offering on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers. What is Inari Medical's stock symbol? Inari Medical trades on the NASDAQ under the ticker symbol "NARI." How do I buy shares of Inari Medical? Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Inari Medical's stock price today? One share of NARI stock can currently be purchased for approximately $66.68. How much money does Inari Medical make? Inari Medical (NASDAQ:NARI) has a market capitalization of $3.82 billion and generates $383.47 million in revenue each year. The company earns $-29,270,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis. How many employees does Inari Medical have? The company employs 1,100 workers across the globe. How can I contact Inari Medical? Inari Medical's mailing address is 9 Parker Suite 100, Irvine CA, 92618. The official website for the company is www.inarimedical.com. The company can be reached via phone at 877-923-4747 or via email at ir@inarimedical.com. This page (NASDAQ:NARI) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.